IA Trial Radar
L'essai clinique NCT07182357 (ENGAGE-D) pour Maladie d'Alzheimer et démences apparentées est pas encore en recrutement. Consultez la vue en carte du Radar des Essais Cliniques et les outils de découverte par IA pour tous les détails, ou posez vos questions ici.
Un essai clinique correspond aux filtres sélectionnés
Vue en carte
Retour à la recherche

Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia (ENGAGE-D) 96

Pas encore en recrutement
Les détails de l'essai clinique sont principalement disponibles en anglais. Cependant, l'IA Trial Radar peut vous aider ! Cliquez simplement sur 'Expliquer l'étude' pour voir et discuter des informations sur l'étude dans la langue sélectionnée.
L'essai clinique NCT07182357 (ENGAGE-D) est une étude interventionnel pour Maladie d'Alzheimer et démences apparentées. Son statut actuel est : pas encore en recrutement. Le recrutement est prévu pour commencer le 1 octobre 2025, avec un objectif de 96 participants. Dirigée par l'Université de New York, l'étude devrait être terminée d'ici le 31 juillet 2028. Les données du site ClinicalTrials.gov ont été mises à jour pour la dernière fois le 19 septembre 2025.
Résumé succinct
This study will test a care management intervention to guide end-of-life care and hospice transitions for persons with dementia and their care partners receiving home healthcare and ascertain feasibility, acceptability, fidelity, and usability of a dementia care management hospice transitions checklist. This study will also examine hospice enrollment, time to enrollment, and care partner satisfaction with the interve...Afficher plus
Description détaillée
This study has the following design: Unblinded, Non-Randomized, Single-Arm Intervention Study (Feasibility Trial). In this study, the team will pilot test the care management checklist intervention with care partners of persons with dementia. This intervention will be tested for feasibility (primary outcome), acceptability, fidelity, and usability (secondary) for in a single arm feasibility trial. The intervention wi...Afficher plus
Titre officiel

ENGAGE-D: Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia

Pathologies
Maladie d'Alzheimer et démences apparentées
Publications
Articles scientifiques et travaux de recherche publiés sur cet essai clinique:
Autres identifiants de l'étude
  • ENGAGE-D
  • i24-00426
Numéro NCT
NCT07182357
Date de début (réel)
2025-10
Dernière mise à jour publiée
2025-09-19
Date de fin (estimée)
2028-07-31
Inscription (estimée)
96
Type d'étude
Interventionnel
PHASE
N/A
Statut
Pas encore en recrutement
Mots clés
hospice care
care transitions
Alzheimer's disease and related dementias
Objectif principal
Soins de soutien
Méthode d'allocation
N/A
Modèle d'intervention
Groupe unique
Masquage
Aucun (ouvert)
Bras / Interventions
Groupe de participants/BrasIntervention/Traitement
ExpérimentalDementia Care Management Checklist for Hospice Transitions
The care management checklist will be administered to care partners by care managers during an outreach call to discuss the person with dementia's care and clinical needs. In this conversation, they will use the checklist to ask questions regarding care needs, decision-making considerations (healthcare proxy, etc), end-of-life dementia education, social and cultural needs, and potential care transitions.
Dementia Care Management Checklist for Hospice Transitions
Intervention: After appropriate care partners of hospice-eligible PLWD are identified who will be receiving the checklist intervention, care managers will perform telephonic outreach to engage them in a conversation about care needs (as they would in typical clinical practice). The telephonic outreach will be followed up with a recommendation for follow up by a medical provider who may conduct a hospice care assessme...Afficher plus
Critère principal d'évaluation
Critères d'évaluationDescription de la mesurePériode
Feasibility of the Dementia Care Management Hospice Transitions Checklist
The primary outcome is feasibility. Feasibility will be measured for each group including recruitment and retention rates, rate of completion of the intervention as the proportion of individuals who use and receive the intervention, and whether the different components of the intervention are achievable.
After enrollment and study participation, we will collect feasibility data within 1 month after intervention receipt.
Critère secondaire d'évaluation
Critères d'évaluationDescription de la mesurePériode
Acceptability of the Dementia Care Management Hospice Transitions Checklist
The secondary outcome is acceptability. Acceptability will be reflected in process measures required in a transitional care management intervention. For example, intervention components will be measured including if the care manager/interventionist successfully receives the training and resources to successfully deliver the intervention and the number of HHC professionals for whom the intervention was acceptable. Outcome measure: Percentage of participants who find the intervention acceptable.
After intervention delivery, we will collect secondary outcome data within 1 month.
Assistant à la participation
Critères d'éligibilité

Inclusion:

Care Partners and PLWD Dyad:

  1. Care partners of PLWD who have a diagnosis of moderate to severe dementia.
  2. Able to provide informed consent

HHC Professionals:

Care Managers and Field Nurses:

  1. Care managers who regularly engage hospice transitions with care partners of PLWD
  2. Age 18 or older

Medical Providers:

  1. Medical providers (e.g., physicians and nurse practitioners) who refer patients for hospice enrollment.
  2. Age 18 or older

HHC Administrators:

  1. Home healthcare administrators who work with the Certified Home Health Agency or the Advanced Illness Management Program that refers patients to hospice care
  2. Age 18 or older

Exclusion

Care Partner and PLWD Dyad

  1. Under age 18
  2. Care partners who are caring for PLWD with Mild Cognitive Impairment
  3. PLWD with Mild Cognitive Impairment

HHC Professionals: Care Managers, Medical Providers, Administrators

1. Do not have experience managing hospice transitions for PLWD

New York University logoUniversité de New York
Visiting Nurse Service of New York logoVisiting Nurse Service of New York
Contact central de l'étude
Contact: Komal P Murali, PhD, RN, ACNP-BC, 212-998-5783, [email protected]
1 Centres de l'étude dans 1 pays

New York

NYU Rory Meyers College of Nursing and VNS Health, New York, New York, 10010, United States
Komal P Murali, PhD, RN, ACNP-BC, Contact, 212-998-5783, [email protected]
Komal P Murali, PhD, RN, ACNP-BC, Investigateur principal